Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2Breast 1

Conditions

Breast Neoplasms 55Neoplasms 27Prostatic Neoplasms 18Lung Neoplasms 17Head and Neck Neoplasms 14Motor Activity 12Colorectal Neoplasms 12Gastrointestinal Neoplasms 9Ovarian Neoplasms 7Neoplasm Metastasis 7Endometrial Neoplasms 7Anxiety Disorders 7Lymphoma 6Carcinoma, Non-Small-Cell Lung 6Uterine Cervical Neoplasms 5Rectal Neoplasms 5Pancreatic Neoplasms 5Pain 5Colonic Neoplasms 5Carcinoma, Renal Cell 5Smoking Cessation 4Sarcoma 4Recurrence 4Multiple Myeloma 4Melanoma 4Hematologic Neoplasms 4Fatigue 4Esophageal Neoplasms 4Depression 4Tobacco Use Cessation 3

Interventions

Blood Specimen Collection 3Surveys and Questionnaires 2Practice Guidelines as Topic 1Methods 1Magnetic Resonance Spectroscopy 1Lasers, Semiconductor 1Hyperthermia, Induced 1Hematologic Tests 1Health Promotion 1Focus Groups 1Exercise 1Educational Status 1Cytidine Diphosphate Choline 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Uveal Melanoma × Surveys and Questionnaires × Clear all
NCT04118062 2025-09-19

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

Institut Curie

Phase NA Completed
128 enrolled
BreastDermatologic

Uveal Melanoma, Neoplasms, Triple Negative Breast Neoplasms

NCT04728113 2025-09-08

EARLY TOGETHER

Institut Curie

Phase NA Completed
162 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡